Literature DB >> 29476202

Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: a case report.

Hiroshi Uei1, Yasuaki Tokuhashi2, Masafumi Maseda2, Masahiro Nakahashi2, Enshi Nakayama2.   

Abstract

Surgical treatment of multiple vertebral fractures in patients with glucocorticoid-induced osteoporosis is difficult because of a high rate of secondary fracture postoperatively. A case is described in which initial treatment with teriparatide to improve osteoporosis followed by treatment of kyphosis with correction fusion achieved a favorable outcome.
INTRODUCTION: Secondary fracture frequently occurs after treatment of vertebral fracture with vertebroplasty and balloon kyphoplasty in patients with glucocorticoid-induced osteoporosis, but effective treatment of multiple vertebral fractures has rarely been reported. Thus, a treatment of kyphosis following multiple vertebral fractures associated with glucocorticoid-induced osteoporosis is required.
METHODS: The patient was a 24-year-old woman diagnosed with glucocorticoid-induced osteoporosis who was under treatment with oral alendronate, vitamin D, and elcatonin injection. Secondary multiple vertebral fractures occurred despite these treatments and low back pain gradually aggravated.
RESULTS: Vertebroplasty or balloon kyphoplasty was not performed in the early phase. Instead, treatment with teriparatide was used for initial improvement of osteoporosis. Kyphosis in the center of the residual thoracolumbar junction was then treated with posterior correction fusion. At 2 years after surgery, the corrected position has been maintained and no new fracture has occurred.
CONCLUSION: There is no established method for treatment of multiple vertebral fractures caused by glucocorticoid-induced osteoporosis. Initial treatment with teriparatide to improve osteoporosis followed by treatment of kyphosis with correction fusion may result in a more favorable outcome.

Entities:  

Keywords:  Glucocorticoid-induced osteoporosis; Kyphosis; Teriparatide; Vertebral compression fracture

Mesh:

Substances:

Year:  2018        PMID: 29476202     DOI: 10.1007/s00198-018-4425-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  20 in total

Review 1.  Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.

Authors:  M A Amiche; J M Albaum; M Tadrous; P Pechlivanoglou; L E Lévesque; J D Adachi; S M Cadarette
Journal:  Osteoporos Int       Date:  2016-01-18       Impact factor: 4.507

2.  Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis.

Authors:  Gen Inoue; Masaki Ueno; Toshiyuki Nakazawa; Takayuki Imura; Wataru Saito; Kentaro Uchida; Seiji Ohtori; Tomoaki Toyone; Naonobu Takahira; Masashi Takaso
Journal:  J Neurosurg Spine       Date:  2014-06-06

Review 3.  Meta-analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures.

Authors:  Paul A Anderson; Alexander B Froyshteter; William L Tontz
Journal:  J Bone Miner Res       Date:  2013-02       Impact factor: 6.741

4.  Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Authors:  S Cohen; R M Levy; M Keller; E Boling; R D Emkey; M Greenwald; T M Zizic; S Wallach; K L Sewell; B P Lukert; D W Axelrod; A A Chines
Journal:  Arthritis Rheum       Date:  1999-11

5.  Percutaneous vertebroplasty using hydroxyapatite blocks for the treatment of vertebral body fracture.

Authors:  Kazuya Nishioka; Shinji Imae; Mari Kitayama; Jun-Ichiro Miki; Toshika Okawa; Toru Itakura
Journal:  Neurol Med Chir (Tokyo)       Date:  2009-11       Impact factor: 1.742

6.  Primary and secondary osteoporosis' incidence of subsequent vertebral compression fractures after kyphoplasty.

Authors:  James S Harrop; Bronco Prpa; Mary Kay Reinhardt; Isador Lieberman
Journal:  Spine (Phila Pa 1976)       Date:  2004-10-01       Impact factor: 3.468

7.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

8.  Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective.

Authors:  Seiji Ohtori; Gen Inoue; Sumihisa Orita; Kazuyo Yamauchi; Yawara Eguchi; Nobuyasu Ochiai; Shunji Kishida; Kazuki Kuniyoshi; Yasuchika Aoki; Junichi Nakamura; Tetsuhiro Ishikawa; Masayuki Miyagi; Hiroto Kamoda; Miyako Suzuki; Gou Kubota; Yoshihiro Sakuma; Yasuhiro Oikawa; Kazuhide Inage; Takeshi Sainoh; Masashi Takaso; Tomoaki Toyone; Kazuhisa Takahashi
Journal:  Spine (Phila Pa 1976)       Date:  2013-04-15       Impact factor: 3.468

9.  Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.

Authors:  T P Van Staa; R F Laan; I P Barton; S Cohen; D M Reid; C Cooper
Journal:  Arthritis Rheum       Date:  2003-11

10.  Real-life results of balloon kyphoplasty for vertebral compression fractures from the SWISSspine registry.

Authors:  Lars Hübschle; Fredrik Borgström; Gylfi Olafsson; Christoph Röder; Patrick Moulin; Albrecht W Popp; Fabrice Külling; Emin Aghayev
Journal:  Spine J       Date:  2013-12-27       Impact factor: 4.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.